Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: A multicentre study

Journal of Hypertension

Volumn 20, Issue 5, 2002, Pages 1007-1014

  Fogari, Roberto ^a   Zoppi, Annalisa ^a   Carretta, Renzo ^a   Veglio, F ^a   Salvetti, Antonio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Indomethacin; Lisinopril; Valsartan

Indexed keywords

ANGIOTENSIN ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; LISINOPRIL; PLACEBO; PROSTAGLANDIN DERIVATIVE; VALSARTAN;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DYSPEPSIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SITTING; SPHYGMOMANOMETER; STANDING; STATISTICAL SIGNIFICANCE;

EID: 0036563253     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200205000-00037     Document Type: Article

References (42)

1. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
2. Indomethacin raises blood pressure in untreated essential hypertensives: A double-blind randomly allocated study vs placebo
3. Non steroidal anti-inflammatory drugs and antihypertensives
4. Differential effects of selective and non-selective prostaglandin synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension
5. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition
6. Indomethacin reduces the antihypertensive action of enalapril
7. Influence of non steroidal anti-inflammatory drugs on renal function and 24 hour ambulatory blood pressure reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients
8. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
9. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects
10. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazepril
11. The role of prostaglandins in the systemic and renal hemodynamic action of lisinopril
12. Angiotensin converting enzyme inhibition and prostaglandins
13. Effects of converting enzyme inhibition on the renin-angiotensin -aldosterone, bradykinin and arachidonic acid-prostaglandin systems: Correlation of chemical structure and biologic activity
14. Kostis JB Angiotensin II receptor antagonists
15. Haemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals
16. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients
17. Effects of 1 gram of oral intravenous aspirin on urinary excretion of TXB2 and 6-keto-PGF-1alpha in healthy subjects
18. Differential effects of selective and non-selective prostaglandins inhibition on the pharmacological responses to captopril in patients with essential hypertension
19. Measurement of plasma renin activity by angiotensin I radioimmunoassay: I. An assessment of some methodological aspects
20. Vascular renin-angiotensin system and neurotransmission in hypertensive persons
21. Effect of converting enzyme inhibitor on prostaglandins synthesis by isolated rat glomeruli
22. Regulation of prostaglandin synthesis in cultured renal medullary interstitial cells
23. Release of prostaglandin E-like substance from canine kidney and bradykinin
24. The AT1 and AT2 angiotensin receptors
25. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure
26. Role of angiotensin II subtype receptors in the blood pressure lowering effect of losartan in salt restricted rats
27. Angiotensin II AT2 subtype receptors: An emerging target for cardiovascular therapy
28. The subtype 2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3-5-monophosphate and AT1-receptor mediated prostaglandin E2 production in conscious rats
29. Carey RM The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
30. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation
31. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
32. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
33. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man
34. Interaction of non steroidal anti-inflammatory drugs with antihypertensive and diuretic agents
35. Effects of indomethacin alone and during diuretic or beta-blockade therapy on blood pressure and the renin angiotensin system in essential hypertension
36. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients
37. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients
38. Influence of indomethacin on the systemic and pulmonary vascular resistance in man
39. The effect of indomethacin on plasma renin activity and aldosterone in essential hypertensive patients
40. Indomethacin-induced rises in blood pressure
41. The effects of indomethacin and sulindac upon the blood pressure of individuals with untreated labile or mild hypertension